|
GB812366A
(en)
|
1955-08-18 |
1959-04-22 |
Wellcome Found |
Improvements in and relating to derivatives of pyrimidine and the preparation thereof
|
|
GB937725A
(en)
|
1960-05-11 |
1963-09-25 |
Ciba Ltd |
Pyrazolo[3:4-d]pyrimidines
|
|
JPS5256693Y2
(enExample)
|
1973-05-14 |
1977-12-21 |
|
|
|
IT1153216B
(it)
|
1981-10-16 |
1987-01-14 |
Schering Ag |
Procedimento per la preparazione di composti cianoeterociclici
|
|
DE3406533A1
(de)
|
1984-02-23 |
1985-08-29 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten
|
|
US5310731A
(en)
|
1984-06-28 |
1994-05-10 |
Whitby Research, Inc. |
N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
|
|
US4911920A
(en)
|
1986-07-30 |
1990-03-27 |
Alcon Laboratories, Inc. |
Sustained release, comfort formulation for glaucoma therapy
|
|
JPS61109797A
(ja)
|
1984-11-01 |
1986-05-28 |
Yuki Gosei Yakuhin Kogyo Kk |
標識化ヌクレオチドおよび標識化ポリヌクレオチド
|
|
FR2588189B1
(fr)
|
1985-10-03 |
1988-12-02 |
Merck Sharp & Dohme |
Composition pharmaceutique de type a transition de phase liquide-gel
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
WO1990003370A1
(en)
|
1988-09-28 |
1990-04-05 |
Microprobe Corporation |
DERIVATIVES OF PYRAZOLO[3,4-d]PYRIMIDINE
|
|
US5428125A
(en)
|
1989-07-17 |
1995-06-27 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
|
US5442039A
(en)
|
1989-07-17 |
1995-08-15 |
The Dow Chemical Company |
Mesogenic polycyanates and thermosets thereof
|
|
US5674998A
(en)
|
1989-09-15 |
1997-10-07 |
Gensia Inc. |
C-4' modified adenosine kinase inhibitors
|
|
US5721356A
(en)
|
1989-09-15 |
1998-02-24 |
Gensia, Inc. |
Orally active adenosine kinase inhibitors
|
|
US5763597A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
Orally active adenosine kinase inhibitors
|
|
US5795977A
(en)
|
1989-09-15 |
1998-08-18 |
Metabasis Therapeutics, Inc. |
Water soluble adenosine kinase inhibitors
|
|
US5646128A
(en)
|
1989-09-15 |
1997-07-08 |
Gensia, Inc. |
Methods for treating adenosine kinase related conditions
|
|
US5763596A
(en)
|
1989-09-15 |
1998-06-09 |
Metabasis Therapeutics, Inc. |
C-4' modified adenosine kinase inhibitors
|
|
GB9009542D0
(en)
|
1990-04-27 |
1990-06-20 |
Beecham Group Plc |
Novel compounds
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
GB9113137D0
(en)
|
1990-07-13 |
1991-08-07 |
Ici Plc |
Thioxo heterocycles
|
|
US5563257A
(en)
|
1990-08-20 |
1996-10-08 |
Boehringer Mannheim Gmbh |
Phospholipid derivatives of nucleosides
|
|
DE4026265A1
(de)
|
1990-08-20 |
1992-02-27 |
Boehringer Mannheim Gmbh |
Neue phospholipid-derivate von nucleosiden, deren herstellung sowie deren verwendung als antivirale arzneimittel
|
|
US5561134A
(en)
|
1990-09-25 |
1996-10-01 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
|
|
SG80526A1
(en)
|
1990-09-25 |
2001-05-22 |
Rhone Poulenc Rorer Int |
Compounds having antihypertensive and anti- ischemic properies
|
|
US5652366A
(en)
|
1990-09-25 |
1997-07-29 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof
|
|
JP2594486B2
(ja)
|
1991-01-15 |
1997-03-26 |
アルコン ラボラトリーズ インコーポレイテッド |
局所的眼薬組成物
|
|
GB9103839D0
(en)
|
1991-02-23 |
1991-04-10 |
Smithkline Beecham Plc |
Pharmaceuticals
|
|
US5212162A
(en)
|
1991-03-27 |
1993-05-18 |
Alcon Laboratories, Inc. |
Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
|
|
IL104369A0
(en)
|
1992-01-13 |
1993-05-13 |
Smithkline Beecham Corp |
Novel compounds and compositions
|
|
US5916891A
(en)
|
1992-01-13 |
1999-06-29 |
Smithkline Beecham Corporation |
Pyrimidinyl imidazoles
|
|
DE4204031A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue lipidphosphonsaeure-nucleosid-konjugate sowie deren verwendung als antivirale arzneimittel
|
|
DE4204032A1
(de)
|
1992-02-12 |
1993-08-19 |
Boehringer Mannheim Gmbh |
Neue liponucleotide, deren herstellunmg sowie deren verwendung als antivirale arzneimittel
|
|
WO1993018035A1
(en)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
|
JP2737518B2
(ja)
|
1992-03-16 |
1998-04-08 |
富士通株式会社 |
赤外線検知器の冷却構造
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
GB9208135D0
(en)
|
1992-04-13 |
1992-05-27 |
Ludwig Inst Cancer Res |
Polypeptides having kinase activity,their preparation and use
|
|
DE69333955D1
(de)
|
1992-04-24 |
2006-02-02 |
Stanford Res Inst Int |
Targeting homologer sequenzen in eukaryotenzellen
|
|
EP0672325B2
(en)
|
1992-06-19 |
2008-08-27 |
Honeywell Inc. |
Infrared camera with thermoelectric temperature stabilization
|
|
US6057305A
(en)
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
TW444018B
(en)
|
1992-12-17 |
2001-07-01 |
Pfizer |
Pyrazolopyrimidines
|
|
AU673055B2
(en)
|
1993-02-03 |
1996-10-24 |
Gensia, Inc. |
Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
|
|
IL108523A0
(en)
|
1993-02-03 |
1994-05-30 |
Gensia Inc |
Pharmaceutical compositions containing adenosine kinase inhibitors for preventing or treating conditions involving inflammatory responses and pain
|
|
US5654307A
(en)
|
1994-01-25 |
1997-08-05 |
Warner-Lambert Company |
Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
|
|
IL112249A
(en)
|
1994-01-25 |
2001-11-25 |
Warner Lambert Co |
Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US6632789B1
(en)
|
1994-04-29 |
2003-10-14 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for modulating T cell responses by manipulating intracellular signal transduction
|
|
DE4418690A1
(de)
|
1994-05-28 |
1996-01-11 |
Boehringer Mannheim Gmbh |
Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
|
|
US6309853B1
(en)
|
1994-08-17 |
2001-10-30 |
The Rockfeller University |
Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
|
|
DK0783505T3
(da)
|
1994-09-29 |
2001-07-02 |
Novartis Ag |
Pyrrolo[2,3-d]pyrimidiner og deres anvendelse
|
|
US6323201B1
(en)
|
1994-12-29 |
2001-11-27 |
The Regents Of The University Of California |
Compounds for inhibition of ceramide-mediated signal transduction
|
|
AU711592B2
(en)
|
1995-04-03 |
1999-10-14 |
Novartis Ag |
Pyrazole derivatives and processes for the preparation thereof
|
|
US6312894B1
(en)
|
1995-04-03 |
2001-11-06 |
Epoch Pharmaceuticals, Inc. |
Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
|
|
US5977061A
(en)
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
|
JPH08295667A
(ja)
|
1995-04-27 |
1996-11-12 |
Takeda Chem Ind Ltd |
複素環化合物、その製造法および剤
|
|
WO1996037777A1
(en)
|
1995-05-23 |
1996-11-28 |
Nelson Randall W |
Mass spectrometric immunoassay
|
|
US5593997A
(en)
|
1995-05-23 |
1997-01-14 |
Pfizer Inc. |
4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
US5665721A
(en)
|
1995-06-07 |
1997-09-09 |
Abbott Laboratories |
Heterocyclic substituted cyclopentane compounds
|
|
IL122246A
(en)
|
1995-06-07 |
2004-06-01 |
Searle & Co |
Combination of spironolactone and angiotensin II antagonist for the treatment of heart failure
|
|
WO1996040256A1
(en)
|
1995-06-07 |
1996-12-19 |
G.D. Searle & Co. |
Method to treat cardiofibrosis with a combination of an angiotensin ii antagonist and spironolactone
|
|
KR100618466B1
(ko)
|
1995-06-07 |
2006-12-13 |
지.디. 썰 엘엘씨 |
울혈성심마비의치료를위한에폭시-스테로이드계알도스테론길항제및앤지오탠신ii길항제복합요법
|
|
ATE483733T1
(de)
|
1995-06-14 |
2010-10-15 |
Univ California |
Hochaffine humane antikörper gegen tumorantigene
|
|
US5763885A
(en)
|
1995-12-19 |
1998-06-09 |
Loral Infrared & Imaging Systems, Inc. |
Method and apparatus for thermal gradient stabilization of microbolometer focal plane arrays
|
|
GB9521987D0
(en)
|
1995-10-26 |
1996-01-03 |
Ludwig Inst Cancer Res |
Phosphoinositide 3-kinase modulators
|
|
JPH09143163A
(ja)
|
1995-11-29 |
1997-06-03 |
Fuji Photo Film Co Ltd |
含窒素ヘテロ芳香族アミド類の製造方法
|
|
US5747235A
(en)
|
1996-01-26 |
1998-05-05 |
Eastman Kodak Company |
Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
|
|
CH690773A5
(de)
|
1996-02-01 |
2001-01-15 |
Novartis Ag |
Pyrrolo(2,3-d)pyrimide und ihre Verwendung.
|
|
DE19603576A1
(de)
|
1996-02-01 |
1997-08-07 |
Bayer Ag |
Acylierte 4-Amino und 4-Hydrazinopyrimidine
|
|
US5914488A
(en)
|
1996-03-05 |
1999-06-22 |
Mitsubishi Denki Kabushiki Kaisha |
Infrared detector
|
|
GB9611460D0
(en)
|
1996-06-01 |
1996-08-07 |
Ludwig Inst Cancer Res |
Novel lipid kinase
|
|
BR9711805A
(pt)
|
1996-06-20 |
2002-01-15 |
Regents The Univesity Of Texas |
Compostos e métodos para providenciar preparações farmacologicamente ativas e uso dos mesmos
|
|
US6342514B1
(en)
|
1996-10-23 |
2002-01-29 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US6251901B1
(en)
|
1996-10-23 |
2001-06-26 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5990169A
(en)
|
1996-10-23 |
1999-11-23 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5919808A
(en)
|
1996-10-23 |
1999-07-06 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US6153631A
(en)
|
1996-10-23 |
2000-11-28 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5948776A
(en)
|
1996-10-23 |
1999-09-07 |
Zymogenetic, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5922753A
(en)
|
1996-10-23 |
1999-07-13 |
Zymogenetics, Inc. |
Methods for treating bone deficit conditions with benzothiazole
|
|
US5994358A
(en)
|
1996-10-23 |
1999-11-30 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
|
US5858753A
(en)
|
1996-11-25 |
1999-01-12 |
Icos Corporation |
Lipid kinase
|
|
JP4094066B2
(ja)
|
1996-12-06 |
2008-06-04 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
インターロイキン−１β変換酵素のインヒビター
|
|
US6093737A
(en)
|
1996-12-30 |
2000-07-25 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JPH10206995A
(ja)
|
1997-01-21 |
1998-08-07 |
Konica Corp |
ハロゲン化銀写真感光材料
|
|
WO1998035048A2
(en)
|
1997-02-07 |
1998-08-13 |
Princeton University |
Engineered protein kinases which can utilize modified nucleotide triphosphate substrates
|
|
ATE242245T1
(de)
|
1997-03-19 |
2003-06-15 |
Basf Ag |
Pyrrolo(2,3-d)pyrimidine und ihre verwendung als tyrosinkinase-inhibitoren
|
|
US7863444B2
(en)
|
1997-03-19 |
2011-01-04 |
Abbott Laboratories |
4-aminopyrrolopyrimidines as kinase inhibitors
|
|
WO1998052611A1
(en)
|
1997-05-23 |
1998-11-26 |
Nippon Shinyaku Co., Ltd. |
Medicinal composition for prevention or treatment of hepatopathy
|
|
US6207679B1
(en)
|
1997-06-19 |
2001-03-27 |
Sepracor, Inc. |
Antimicrobial agents uses and compositions related thereto
|
|
WO1999018077A1
(en)
|
1997-10-02 |
1999-04-15 |
Eisai Co., Ltd. |
Fused pyridine derivatives
|
|
US6649631B1
(en)
|
1997-10-23 |
2003-11-18 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating bone deficit conditions
|
|
WO1999024432A1
(fr)
|
1997-11-12 |
1999-05-20 |
Mitsubishi Chemical Corporation |
Derives de purine et medicament les renfermant en tant qu'ingredient actif
|
|
US6191170B1
(en)
|
1998-01-13 |
2001-02-20 |
Tularik Inc. |
Benzenesulfonamides and benzamides as therapeutic agents
|
|
US7715989B2
(en)
|
1998-04-03 |
2010-05-11 |
Elitech Holding B.V. |
Systems and methods for predicting oligonucleotide melting temperature (TmS)
|
|
US6127121A
(en)
|
1998-04-03 |
2000-10-03 |
Epoch Pharmaceuticals, Inc. |
Oligonucleotides containing pyrazolo[3,4-D]pyrimidines for hybridization and mismatch discrimination
|
|
JP2000072773A
(ja)
|
1998-08-28 |
2000-03-07 |
Zeria Pharmaceut Co Ltd |
プリン誘導体
|
|
SK3842001A3
(en)
|
1998-09-18 |
2002-04-04 |
Basf Ag |
Pyrrolopyrimidines as protein kinase inhibitors (revised)
|
|
US6713474B2
(en)
|
1998-09-18 |
2004-03-30 |
Abbott Gmbh & Co. Kg |
Pyrrolopyrimidines as therapeutic agents
|
|
JP2002527359A
(ja)
|
1998-09-18 |
2002-08-27 |
ビーエーエスエフ アクチェンゲゼルシャフト |
キナーゼインヒビターとしての４−アミノピロリピリミジン
|
|
AU779008C
(en)
|
1999-01-11 |
2005-06-30 |
Princeton University |
High affinity inhibitors for target validation and uses thereof
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
EP1040831A3
(en)
|
1999-04-02 |
2003-05-02 |
Pfizer Products Inc. |
Use of corticotropin releasing factor (CRF) antagonists to prevent sudden death
|
|
SE515856C2
(sv)
|
1999-05-19 |
2001-10-22 |
Ericsson Telefon Ab L M |
Bärare för elektronikkomponenter
|
|
HK1046402A1
(zh)
|
1999-06-03 |
2003-01-10 |
Basf Aktiengesellschaft |
Benzothiazinone和benzoxazinone化合物
|
|
US6387894B1
(en)
|
1999-06-11 |
2002-05-14 |
Pfizer Inc. |
Use of CRF antagonists and renin-angiotensin system inhibitors
|
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
GB9919588D0
(en)
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
|
AU7080500A
(en)
|
1999-08-27 |
2001-03-26 |
Chemocentryx, Inc. |
Compounds and methods for modulating cxcr3 function
|
|
EP1216234B1
(en)
|
1999-09-16 |
2004-12-29 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
IL148718A0
(en)
|
1999-09-17 |
2002-09-12 |
Abbott Gmbh & Co Kg |
Pyrazolopyrimidines as therapeutic agents
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
ES2225231T3
(es)
|
1999-10-06 |
2005-03-16 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Compuestos heterociclicos, utiles como inhibidores de tirosina quinasas.
|
|
US6506769B2
(en)
|
1999-10-06 |
2003-01-14 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic compounds useful as inhibitors of tyrosine kinases
|
|
US6472153B1
(en)
|
1999-10-26 |
2002-10-29 |
Epoch Biosciences, Inc. |
Hybridization-triggered fluorescent detection of nucleic acids
|
|
JP2001151635A
(ja)
|
1999-11-19 |
2001-06-05 |
Lion Corp |
水中油型乳化皮膚外用剤
|
|
US6660845B1
(en)
|
1999-11-23 |
2003-12-09 |
Epoch Biosciences, Inc. |
Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof
|
|
GB0002032D0
(en)
|
2000-01-28 |
2000-03-22 |
Zeneca Ltd |
Chemical compounds
|
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
|
AU2000240570A1
(en)
|
2000-03-29 |
2001-10-08 |
Knoll Gesellschaft Mit Beschraenkter Haftung |
Pyrrolopyrimidines as tyrosine kinase inhibitors
|
|
JP2004514405A
(ja)
|
2000-03-29 |
2004-05-20 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
Ｔｉｅ−２阻害薬の特定方法
|
|
US7115653B2
(en)
|
2000-03-30 |
2006-10-03 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
|
MXPA02010618A
(es)
|
2000-04-25 |
2004-05-05 |
Icos Corp |
Inhibidores de fosfatidilinositol 3-quinasa delta.
|
|
JP2002037787A
(ja)
|
2000-05-16 |
2002-02-06 |
Kyowa Hakko Kogyo Co Ltd |
［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
|
|
US6777439B2
(en)
|
2000-05-30 |
2004-08-17 |
Advanced Research & Technology Institute, Inc. |
Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
|
|
KR20030011371A
(ko)
|
2000-06-27 |
2003-02-07 |
진랩스 테크놀러지스, 인크. |
항세균, 항진균 또는 항암 활성을 갖는 신규 화합물
|
|
US6534691B2
(en)
|
2000-07-18 |
2003-03-18 |
E. I. Du Pont De Nemours And Company |
Manufacturing process for α-olefins
|
|
US6811979B2
(en)
|
2000-10-11 |
2004-11-02 |
Applera Corporation |
Fluorescent nucleobase conjugates having anionic linkers
|
|
AU2002213467A1
(en)
|
2000-10-11 |
2002-04-22 |
Chemocentryx, Inc. |
Modulation of ccr4 function
|
|
JP2002131859A
(ja)
|
2000-10-19 |
2002-05-09 |
Konica Corp |
撮影用赤外感光性ハロゲン化銀写真感光材料及び赤外感光性ハロゲン化銀乳剤
|
|
US6890747B2
(en)
|
2000-10-23 |
2005-05-10 |
Warner-Lambert Company |
Phosphoinositide 3-kinases
|
|
US6964967B2
(en)
|
2000-12-11 |
2005-11-15 |
Amgen, Inc. |
Substituted pyrido[2,3-d]pyrimidines and methods for their use
|
|
TWI312779B
(enExample)
|
2000-12-28 |
2009-08-01 |
Daiichi Seiyaku Co |
|
|
US7105499B2
(en)
|
2001-01-22 |
2006-09-12 |
Merck & Co., Inc. |
Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
|
|
DZ3487A1
(fr)
|
2001-01-22 |
2002-07-25 |
Merck Sharp & Dohme |
Derives de nucleoside comme inhibiteurs de l'arn polymerase virale d'arn-dependant
|
|
CA2439263C
(en)
|
2001-03-02 |
2012-10-23 |
Frank Becker |
Three hybrid assay system
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
US7250569B2
(en)
|
2001-04-26 |
2007-07-31 |
New York University School Of Medicine |
Method for dissolving nanostructural materials
|
|
EP1397350B1
(en)
|
2001-05-08 |
2007-02-28 |
Kudos Pharmaceuticals Limited |
Isoquinolinone derivatives as parp inhibitors
|
|
US7144903B2
(en)
|
2001-05-23 |
2006-12-05 |
Amgen Inc. |
CCR4 antagonists
|
|
JP2005505508A
(ja)
|
2001-06-13 |
2005-02-24 |
ジーンソフト ファーマシューティカルズ インコーポレイテッド |
抗感染活性を有するベンゾチオフェン化合物
|
|
WO2002100832A1
(en)
|
2001-06-13 |
2002-12-19 |
Genesoft Pharmaceuticals, Inc. |
Isoquinoline compounds having antiinfective activity
|
|
US20030236198A1
(en)
|
2001-06-13 |
2003-12-25 |
Genesoft, Inc. |
Antipathogenic benzamide compounds
|
|
EP1463742A4
(en)
|
2001-06-21 |
2006-05-10 |
Ariad Pharma Inc |
NEW PYRAZOLO AND PYRROLO PYRIMIDINES AND THEIR USES
|
|
CA2455181C
(en)
|
2001-08-01 |
2010-04-06 |
Merck & Co., Inc. |
Benzimidazo[4,5-f]isoquinolinone derivatives
|
|
AU2002327422A1
(en)
|
2001-08-03 |
2003-03-18 |
Abbott Laboratories |
Method of identifying inhibitors of lck
|
|
JP4338192B2
(ja)
|
2001-08-10 |
2009-10-07 |
塩野義製薬株式会社 |
抗ウイルス剤
|
|
JP2003073357A
(ja)
|
2001-09-03 |
2003-03-12 |
Mitsubishi Pharma Corp |
アミド化合物を含有するＲｈｏキナーゼ阻害剤
|
|
WO2004043335A2
(en)
|
2001-09-13 |
2004-05-27 |
Genesoft, Inc. |
Methods of treating infection by drug resistant bacteria
|
|
US7101884B2
(en)
|
2001-09-14 |
2006-09-05 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
AUPR769501A0
(en)
|
2001-09-14 |
2001-10-11 |
Biomolecular Research Institute Limited |
Cytokine receptor 1
|
|
WO2003032989A1
(en)
*
|
2001-10-18 |
2003-04-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
|
|
TWI330183B
(enExample)
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
|
US7319858B2
(en)
|
2001-11-16 |
2008-01-15 |
Cingular Wireless Ii, Llc |
System and method for querying message information
|
|
WO2003048081A2
(en)
|
2001-12-04 |
2003-06-12 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
JP4085237B2
(ja)
|
2001-12-21 |
2008-05-14 |
日本電気株式会社 |
携帯電話の利用契約システムと通信方法
|
|
US7998986B2
(en)
|
2001-12-21 |
2011-08-16 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
WO2003057212A1
(en)
|
2001-12-26 |
2003-07-17 |
Genelabs Technologies, Inc. |
Polyamide derivatives possessing antibacterial, antifungal or antitumor activity
|
|
US7414036B2
(en)
|
2002-01-25 |
2008-08-19 |
Muscagen Limited |
Compounds useful as A3 adenosine receptor agonists
|
|
AU2003225933A1
(en)
|
2002-03-22 |
2003-10-13 |
Cellular Genomics, Inc. |
AN IMPROVED FORMULATION OF CERTAIN PYRAZOLO(3,4-d) PYRIMIDINES AS KINASE MODULATORS
|
|
WO2003080582A2
(de)
|
2002-03-26 |
2003-10-02 |
Biofrontera Discovery Gmbh |
Fredericamycin-derivate
|
|
US7166293B2
(en)
|
2002-03-29 |
2007-01-23 |
Carlsbad Technology, Inc. |
Angiogenesis inhibitors
|
|
DE10217046A1
(de)
|
2002-04-17 |
2003-11-06 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
|
JP2005529889A
(ja)
|
2002-04-26 |
2005-10-06 |
ファイザー・プロダクツ・インク |
ピリミジン−２，４，６−トリオンメタロ−プロテイナーゼ阻害剤
|
|
US6794562B2
(en)
|
2002-05-01 |
2004-09-21 |
Stine Seed Farm, Inc. |
Soybean cultivar 0332143
|
|
JP2006506401A
(ja)
|
2002-05-23 |
2006-02-23 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害薬
|
|
EP1556357A4
(en)
|
2002-06-14 |
2006-09-13 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
US7265111B2
(en)
|
2002-06-27 |
2007-09-04 |
Sanofi-Aventis Deutschland Gmbh |
Adenosine analogues and their use as pharmaceutical agents
|
|
AU2003243921B2
(en)
|
2002-06-27 |
2009-05-07 |
Novo Nordisk A/S |
Aryl carbonyl derivatives as therapeutic agents
|
|
KR101124245B1
(ko)
|
2002-06-27 |
2012-07-02 |
노보 노르디스크 에이/에스 |
치료제로서 아릴 카르보닐 유도체
|
|
DE10230917A1
(de)
|
2002-07-09 |
2004-02-05 |
Bioleads Gmbh |
Fredericamycin-Derivate
|
|
WO2004006906A2
(en)
|
2002-07-15 |
2004-01-22 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
|
BR0313460A
(pt)
|
2002-08-13 |
2005-07-05 |
Warner Lambert Co |
Derivados de naftaleno como inibidores de metaloproteinase da matriz
|
|
NZ538420A
(en)
|
2002-08-16 |
2007-06-29 |
Kinacia Pty Ltd |
Inhibition of phosphoinositide 3-kinase beta
|
|
AU2003262747A1
(en)
|
2002-08-21 |
2004-03-11 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
|
US20030139427A1
(en)
|
2002-08-23 |
2003-07-24 |
Osi Pharmaceuticals Inc. |
Bicyclic pyrimidinyl derivatives and methods of use thereof
|
|
JP2006515163A
(ja)
|
2002-08-30 |
2006-05-25 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Ｘｂｐ−１活性を調整するための方法および組成物
|
|
WO2004022562A1
(en)
*
|
2002-09-09 |
2004-03-18 |
Cellular Genomics, Inc. |
6-ARYL-IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES, METHOD OF MAKING, AND METHOD OF USE THEREOF
|
|
WO2004031177A1
(ja)
|
2002-09-30 |
2004-04-15 |
Banyu Pharmaceutical Co., Ltd. |
２−アミノベンズイミダゾール誘導体
|
|
JP2004161716A
(ja)
|
2002-11-15 |
2004-06-10 |
Takeda Chem Ind Ltd |
Ｊｎｋ阻害剤
|
|
UA80171C2
(en)
|
2002-12-19 |
2007-08-27 |
Pfizer Prod Inc |
Pyrrolopyrimidine derivatives
|
|
ATE496893T1
(de)
|
2002-12-20 |
2011-02-15 |
X Ceptor Therapeutics Inc |
Isochinolinonderivate und deren verwendung als medikamente
|
|
WO2004056746A1
(en)
|
2002-12-23 |
2004-07-08 |
4Sc Ag |
Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
|
US7247736B2
(en)
|
2002-12-23 |
2007-07-24 |
4Sc Ag |
Method of identifying inhibitors of DHODH
|
|
US7365094B2
(en)
|
2002-12-23 |
2008-04-29 |
4Sc Ag |
Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
|
WO2004078702A1
(en)
|
2003-03-06 |
2004-09-16 |
Dsm Ip Assets B.V. |
PROCESS FOR THE PREPARATION OF AN α-AMINO CARBONYL COMPOUND
|
|
US20040242568A1
(en)
|
2003-03-25 |
2004-12-02 |
Syrrx, Inc. |
Dipeptidyl peptidase inhibitors
|
|
GB0306907D0
(en)
|
2003-03-26 |
2003-04-30 |
Angiogene Pharm Ltd |
Boireductively-activated prodrugs
|
|
WO2004103270A2
(en)
|
2003-04-02 |
2004-12-02 |
Suntory Pharmaceutical Research Laboratories Llc |
Compounds and methods for treatment of thrombosis
|
|
US20050008640A1
(en)
|
2003-04-23 |
2005-01-13 |
Wendy Waegell |
Method of treating transplant rejection
|
|
EP1646615B1
(en)
|
2003-06-06 |
2009-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
US7429596B2
(en)
|
2003-06-20 |
2008-09-30 |
The Regents Of The University Of California |
1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
|
|
EP1680125A1
(en)
|
2003-07-02 |
2006-07-19 |
Warner-Lambert Company LLC |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
|
GB0317951D0
(en)
|
2003-07-31 |
2003-09-03 |
Trigen Ltd |
Compounds
|
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
US7501538B2
(en)
|
2003-08-08 |
2009-03-10 |
Transtech Pharma, Inc. |
Aryl and heteroaryl compounds, compositions and methods of use
|
|
WO2005016349A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Methods of inhibiting leukocyte accumulation
|
|
WO2005016348A1
(en)
|
2003-08-14 |
2005-02-24 |
Icos Corporation |
Method of inhibiting immune responses stimulated by an endogenous factor
|
|
US20050124637A1
(en)
|
2003-08-15 |
2005-06-09 |
Irm Llc |
Compounds and compositions as inhibitors of receptor tyrosine kinase activity
|
|
US7390820B2
(en)
|
2003-08-25 |
2008-06-24 |
Amgen Inc. |
Substituted quinolinone derivatives and methods of use
|
|
WO2005044181A2
(en)
|
2003-09-09 |
2005-05-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors
|
|
GB0322409D0
(en)
|
2003-09-25 |
2003-10-29 |
Astrazeneca Ab |
Quinazoline derivatives
|
|
UA83509C2
(en)
|
2003-10-15 |
2008-07-25 |
Оси Фармасьютикалз, Инк. |
Imidazopyrazines as tyrosine kinase inhibitors
|
|
EP1687002A4
(en)
|
2003-11-10 |
2008-07-23 |
Synta Pharmaceuticals Corp |
CONDENSED HETEROCYCLIC COMPOUNDS
|
|
CA2546192C
(en)
|
2003-11-17 |
2010-04-06 |
Pfizer Products Inc. |
Pyrrolopyrimidine compounds useful in treatment of cancer
|
|
JP2007513154A
(ja)
|
2003-12-08 |
2007-05-24 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物及び方法
|
|
WO2005063258A1
(en)
|
2003-12-22 |
2005-07-14 |
Gilead Sciences, Inc. |
Kinase inhibitor phosphonate conjugates
|
|
DE602004025504D1
(de)
|
2003-12-23 |
2010-03-25 |
Novartis Ag |
Bicyclische heterocyclische p-38-kinase-inhibitoren
|
|
CA2552664A1
(en)
|
2004-01-08 |
2005-07-28 |
Michigan State University |
Methods for treating and preventing hypertension and hypertension-related disorders
|
|
JP2007520559A
(ja)
|
2004-02-03 |
2007-07-26 |
アボット・ラボラトリーズ |
治療薬としてのアミノベンゾオキサゾール類
|
|
CA2555824C
(en)
|
2004-02-13 |
2011-06-07 |
Banyu Pharmaceutical Co., Ltd. |
Fused-ring 4-oxopyrimidine derivative
|
|
US20050187418A1
(en)
|
2004-02-19 |
2005-08-25 |
Small Brooke L. |
Olefin oligomerization
|
|
EP1720874A4
(en)
|
2004-02-24 |
2010-03-03 |
Bioaxone Therapeutique Inc |
4-SUBSTITUTED PIPERIDINE DERIVATIVES
|
|
CA2557575A1
(en)
|
2004-02-27 |
2005-09-15 |
F. Hoffmann-La Roche Ag |
Fused derivatives of pyrazole
|
|
DE602005014964D1
(de)
*
|
2004-04-02 |
2009-07-30 |
Osi Pharm Inc |
Mit einem 6,6-bicyclischen ring substituierte heterobicyclische proteinkinaseinhibitoren
|
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
|
AU2005238386A1
(en)
|
2004-04-30 |
2005-11-10 |
Takeda Pharmaceutical Company Limited |
Heterocyclic amide compound and use thereof as an MMP-13 inhibitor
|
|
DE102004022897A1
(de)
|
2004-05-10 |
2005-12-08 |
Bayer Cropscience Ag |
Azinyl-imidazoazine
|
|
PL1761540T3
(pl)
|
2004-05-13 |
2017-06-30 |
Icos Corporation |
Chinazolinony jako inhibitory ludzkiej kinazy 3-fosfatydyloinozytolu delta
|
|
CA2566436C
(en)
|
2004-05-13 |
2011-05-10 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
|
JP2008500338A
(ja)
|
2004-05-25 |
2008-01-10 |
イコス・コーポレイション |
造血細胞の異常増殖を治療及び／又は予防する方法
|
|
BRPI0511512A
(pt)
|
2004-05-27 |
2007-12-26 |
Pfizer Prod Inc |
derivados pirrolpirimidina úteis no tratamento do cáncer
|
|
EP1750715A1
(en)
|
2004-06-04 |
2007-02-14 |
Icos Corporation |
Methods for treating mast cell disorders
|
|
GB0420722D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
WO2006038865A1
(en)
|
2004-10-01 |
2006-04-13 |
Betagenon Ab |
Nucleotide derivatives for the treatment of type 2 diabetes and other disorders
|
|
GB0423554D0
(en)
*
|
2004-10-22 |
2004-11-24 |
Cancer Rec Tech Ltd |
Therapeutic compounds
|
|
US7622451B2
(en)
|
2004-11-03 |
2009-11-24 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
|
CA2585091C
(en)
|
2004-11-03 |
2016-07-19 |
University Of Kansas |
Novobiocin analogues as anticancer agents
|
|
US8212012B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues having modified sugar moieties
|
|
US8212011B2
(en)
|
2004-11-03 |
2012-07-03 |
University Of Kansas |
Novobiocin analogues
|
|
GB0425035D0
(en)
|
2004-11-12 |
2004-12-15 |
Novartis Ag |
Organic compounds
|
|
US9512125B2
(en)
|
2004-11-19 |
2016-12-06 |
The Regents Of The University Of California |
Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
|
|
JP2008520742A
(ja)
|
2004-11-23 |
2008-06-19 |
ピーティーシー セラピューティクス， インコーポレイテッド |
Ｖｅｇｆ産生の阻害に有用なカルバゾール誘導体、カルボリン誘導体およびインドール誘導体
|
|
US20060156485A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
EP1885356A2
(en)
|
2005-02-17 |
2008-02-13 |
Icos Corporation |
Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation
|
|
WO2006091897A2
(en)
|
2005-02-25 |
2006-08-31 |
Adenosine Therapeutics, Llc |
Derivatives of 8-substituted xanthines
|
|
US20090124654A1
(en)
|
2005-03-01 |
2009-05-14 |
Mjalli Adnan M M |
Aryl and Heteroaryl Compounds, Compositions, Methods of Use
|
|
RU2007138264A
(ru)
|
2005-03-17 |
2009-09-10 |
Новартис АГ (CH) |
N-[3-(1-АМИНО-5,6,7,8-ТЕТРАГИДРО-2,4,4b-ТРИАЗАФЛУОРЕН-9-ИЛ)ФЕНИЛ]БЕНЗАМИДЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ТИРОЗИН/ТРЕОНИНКИНАЗ, ПРЕЖДЕ ВСЕГО КИНАЗ В-RAF
|
|
WO2006108107A1
(en)
|
2005-04-06 |
2006-10-12 |
Irm Llc |
Diarylamine-containing compounds and compositions, and their use as modulators of steroid hormone nuclear receptors
|
|
KR100781704B1
(ko)
|
2005-04-20 |
2007-12-03 |
에스케이케미칼주식회사 |
피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
|
|
WO2006114180A1
(de)
|
2005-04-25 |
2006-11-02 |
Merck Patent Gmbh |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
|
WO2006114064A2
(en)
|
2005-04-25 |
2006-11-02 |
Institute Of Organic Chemistry And Biochemistry Ofthe Academy Of Sciences Of The Czech Republic |
Use of compounds to enhance processivity of telomerase
|
|
MX2007015917A
(es)
|
2005-06-22 |
2008-03-10 |
Chemocentryx Inc |
Compuestos de azaindazol y metodos de uso.
|
|
ATE474829T1
(de)
|
2005-06-27 |
2010-08-15 |
Amgen Inc |
Entzündungshemmende arylnitrilverbindungen
|
|
WO2007006547A1
(en)
|
2005-07-11 |
2007-01-18 |
Devgen N.V. |
Amide derivatives as kinase inhibitors
|
|
JP2009505948A
(ja)
|
2005-07-11 |
2009-02-12 |
デブジェン エヌブイ |
キナーゼ阻害剤としてのアミド誘導体
|
|
GB0516723D0
(en)
|
2005-08-15 |
2005-09-21 |
Novartis Ag |
Organic compounds
|
|
AU2006283940A1
(en)
|
2005-08-25 |
2007-03-01 |
F. Hoffmann-La Roche Ag |
P38 MAP kinase inhibitors and methods for using the same
|
|
WO2007025090A2
(en)
|
2005-08-25 |
2007-03-01 |
Kalypsys, Inc. |
Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase
|
|
WO2007025534A1
(de)
|
2005-09-01 |
2007-03-08 |
Bioagency Ag |
Fredericamycin-derivate
|
|
JP2009510066A
(ja)
|
2005-09-29 |
2009-03-12 |
ワイス |
血管運動症状（ｖｍｓ）の治療のためのモノアミン再取り込みのモジュレータである１−（１ｈ−インドール−１−イル）−３−（メチルアミノ）−１−フェニルプロパン−２−オール誘導体および関連の化合物
|
|
AU2006316605B2
(en)
|
2005-11-17 |
2012-04-26 |
Osi Pharmaceuticals, Inc. |
Fused bicyclic mTOR inhibitors
|
|
US20090088452A1
(en)
|
2005-11-22 |
2009-04-02 |
Coleman Paul J |
Indole Orexin Receptor Antagonists
|
|
AR057960A1
(es)
*
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
|
WO2007066189A2
(en)
|
2005-12-09 |
2007-06-14 |
Pfizer Products Inc. |
Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
|
|
WO2007075554A2
(en)
|
2005-12-19 |
2007-07-05 |
Osi Pharmaceuticals, Inc. |
Combination of igfr inhibitor and anti-cancer agent
|
|
WO2007079164A2
(en)
|
2005-12-29 |
2007-07-12 |
Abbott Laboratories |
Protein kinase inhibitors
|
|
WO2007089669A2
(en)
|
2006-01-26 |
2007-08-09 |
Wyeth |
Processes for the preparation of compounds which modulate cell proliferation
|
|
CA2641254A1
(en)
|
2006-02-14 |
2007-08-23 |
Vertex Pharmaceuticals Incorporated |
Pyrrolo(3,2-c) pyridines useful as inhibitors of protein kinases
|
|
CA2638734A1
(en)
|
2006-02-27 |
2007-09-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Inhibitors of the unfolded protein response and methods for their use
|
|
CA2645137A1
(en)
|
2006-03-07 |
2007-09-13 |
James F. Blake |
Heterobicyclic pyrazole compounds and methods of use
|
|
WO2007106503A2
(en)
*
|
2006-03-13 |
2007-09-20 |
Osi Pharmaceuticals, Inc. |
Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors
|
|
HRP20160990T1
(hr)
|
2006-03-24 |
2016-10-07 |
Biogen Hemophilia Inc. |
Pc5 kao enzim obrade faktor ix propeptida
|
|
JP2009531443A
(ja)
|
2006-03-29 |
2009-09-03 |
フォールドアールエックス ファーマシューティカルズ インコーポレーティッド |
α−シヌクレイン毒性の抑制
|
|
KR101499783B1
(ko)
|
2006-04-04 |
2015-03-09 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
키나제 길항물질
|
|
WO2007121453A2
(en)
|
2006-04-17 |
2007-10-25 |
The Regents Of The University Of California |
2-hydroxy-1-oxo 1,2 dihydro isoquinoline chelating agents
|
|
GB0607948D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
|
GB0607950D0
(en)
|
2006-04-21 |
2006-05-31 |
Novartis Ag |
Organic compounds
|
|
PE20080361A1
(es)
|
2006-04-21 |
2008-06-03 |
Novartis Ag |
Compuestos derivados de purina como activadores del receptor de adenosina a2a
|
|
US20090082370A1
(en)
|
2006-04-25 |
2009-03-26 |
Neil Thomas Thompson |
Pharmaceutical Combinations of PK Inhibitors and Other Active Agents
|
|
WO2007125315A2
(en)
|
2006-04-25 |
2007-11-08 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
|
DE102006020327A1
(de)
|
2006-04-27 |
2007-12-27 |
Bayer Healthcare Ag |
Heterocyclisch substituierte, anellierte Pyrazol-Derivate und ihre Verwendung
|
|
EP2029593A1
(en)
|
2006-05-22 |
2009-03-04 |
AstraZeneca AB |
Indole derivatives
|
|
GB0610242D0
(en)
|
2006-05-23 |
2006-07-05 |
Novartis Ag |
Organic compounds
|
|
GB0610317D0
(en)
|
2006-05-24 |
2006-07-05 |
Medical Res Council |
Antiparasitic compounds and compositions
|
|
EP2079724B1
(en)
|
2006-07-20 |
2010-05-26 |
Amgen Inc. |
Substituted pyridone compounds and methods of use
|
|
CA2661307C
(en)
|
2006-08-22 |
2016-07-19 |
Technion Research And Development Foundation Ltd. |
Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr)
|
|
EP2069325A2
(en)
|
2006-08-24 |
2009-06-17 |
Serenex, Inc. |
Isoquinoline, quinazoline and phthalazine derivatives
|
|
WO2008025755A1
(de)
|
2006-09-01 |
2008-03-06 |
Basf Se |
Verwendung von n-haltigen heterozyklen in dermokosmetika
|
|
CA2974246C
(en)
|
2006-09-01 |
2020-02-25 |
Senhwa Biosciences, Inc. |
Tricyclic heteroaryl compounds and their use as protein modulators
|
|
EP1903044A1
(en)
|
2006-09-14 |
2008-03-26 |
Novartis AG |
Adenosine Derivatives as A2A Receptor Agonists
|
|
RU2009115954A
(ru)
|
2006-09-29 |
2010-11-10 |
Новартис АГ (CH) |
Пиразолопиримидины в качестве ингибиторов липидной киназы р13к
|
|
JP5306818B2
(ja)
|
2006-10-18 |
2013-10-02 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
US7772180B2
(en)
|
2006-11-09 |
2010-08-10 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
SG178786A1
(en)
|
2006-11-13 |
2012-03-29 |
Lilly Co Eli |
Thienopyrimidinones for treatment of inflammatory disorders and cancers
|
|
WO2008063625A2
(en)
|
2006-11-20 |
2008-05-29 |
Adolor Corporation |
Pyridine compounds and methods of their use
|
|
CN101611007A
(zh)
|
2006-12-20 |
2009-12-23 |
先灵公司 |
新颖的jnk抑制剂
|
|
KR20090101278A
(ko)
|
2006-12-22 |
2009-09-24 |
인더스트리얼 리서치 리미티드 |
누클레오시다제 및 포스포릴라제 억제제의 아제티딘 유사체
|
|
EP2124954A2
(en)
|
2007-01-26 |
2009-12-02 |
Irm Llc |
Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases
|
|
WO2008112715A2
(en)
|
2007-03-12 |
2008-09-18 |
Vm Discovery Inc. |
Novel agents of calcium ion channel modulators
|
|
AU2008231304B2
(en)
|
2007-03-23 |
2011-05-12 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
US7705018B2
(en)
|
2007-03-23 |
2010-04-27 |
Amgen Inc. |
Substituted quinolines and their uses in treatment of inflammatory and related conditions
|
|
EP2132207A2
(en)
|
2007-03-23 |
2009-12-16 |
Amgen Inc. |
Heterocyclic compounds and their uses
|
|
US7867983B2
(en)
|
2007-03-29 |
2011-01-11 |
The University Of Connecticut |
Methods to protect skeletal muscle against injury
|
|
KR20100015546A
(ko)
|
2007-04-13 |
2010-02-12 |
사노피-아벤티스 |
Ｎ-아미노인돌의 전이 금속 촉매된 합성
|
|
WO2008125014A1
(fr)
|
2007-04-13 |
2008-10-23 |
Institute Of Pharmacology And Toxicology Academy Of Military Medical Sciences P.L.A. |
Composés d'urée, leurs procédés de préparation et leurs utilisations pharmaceutiques
|
|
JP2010163361A
(ja)
|
2007-04-27 |
2010-07-29 |
Dainippon Sumitomo Pharma Co Ltd |
キノリン誘導体
|
|
ATE527264T1
(de)
*
|
2007-05-09 |
2011-10-15 |
Abbott Lab |
Kondensierte heterozyklische verbindungen als hemmer von proteinkinasen
|
|
WO2008141140A1
(en)
*
|
2007-05-09 |
2008-11-20 |
Abbott Laboratories |
Condensed heterocyclic compounds as inhibitors of protein kinases
|
|
US7960353B2
(en)
|
2007-05-10 |
2011-06-14 |
University Of Kansas |
Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders
|
|
US20090214529A9
(en)
|
2007-05-22 |
2009-08-27 |
Taigen Biotechnology Co., Ltd. |
Kinesin inhibitors
|
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
EP2520561B1
(en)
|
2007-06-08 |
2016-02-10 |
MannKind Corporation |
IRE-1A Inhibitors
|
|
ATE538120T1
(de)
|
2007-06-26 |
2012-01-15 |
Sanofi Sa |
Regioselektive, metallkatalysierte synthese annelierter benzimidazole und azabenzimidazole
|
|
WO2009004621A1
(en)
|
2007-07-02 |
2009-01-08 |
Technion Research & Development Foundation Ltd. |
Compositions, articles and methods comprising tspo ligands for preventing or reducing tobacco-associated damage
|
|
RU2345996C1
(ru)
|
2007-07-17 |
2009-02-10 |
Андрей Александрович Иващенко |
Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
|
|
US20090053192A1
(en)
|
2007-08-10 |
2009-02-26 |
Burnham Institute For Medical Research |
Tissue-nonspecific alkaline phosphatase (tnap) activators and uses thereof
|
|
CA2695583A1
(en)
|
2007-08-13 |
2009-02-19 |
Metabasis Therapeutics, Inc. |
Novel activators of glucokinase
|
|
WO2009044707A1
(ja)
|
2007-10-03 |
2009-04-09 |
Riken |
ニトロトリアゾール誘導体、およびそれを用いる化合物の製造方法
|
|
JP2011500657A
(ja)
|
2007-10-15 |
2011-01-06 |
アストラゼネカ アクチボラグ |
組合せ０５９
|
|
JP5256693B2
(ja)
|
2007-10-31 |
2013-08-07 |
信越化学工業株式会社 |
酸化チタン系光触媒薄膜の製造法
|
|
AU2008323694A1
(en)
|
2007-11-07 |
2009-05-14 |
Foldrx Pharmaceuticals, Inc. |
Modulation of protein trafficking
|
|
NZ585460A
(en)
|
2007-11-13 |
2013-02-22 |
Icos Corp |
Inhibitors of human phosphatidyl-inositol 3-kinase delta
|
|
CA2708391A1
(en)
|
2007-12-13 |
2009-06-25 |
Sri International |
Ppar-delta ligands and methods of their use
|
|
US7960397B2
(en)
|
2007-12-28 |
2011-06-14 |
Institute Of Experimental Botany, Academy Of Sciences Of The Czech Republic |
6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
|
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
|
AU2009204483B2
(en)
|
2008-01-04 |
2014-03-13 |
Intellikine, Llc |
Certain chemical entities, compositions and methods
|
|
CN101938904A
(zh)
|
2008-01-09 |
2011-01-05 |
PGx健康有限责任公司 |
用a2ar激动剂鞘内治疗神经性疼痛
|
|
JP2011510018A
(ja)
|
2008-01-18 |
2011-03-31 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
癌治療のためのイミダゾピラジノール誘導体
|
|
EP2244709A4
(en)
|
2008-02-07 |
2012-02-29 |
Synta Pharmaceuticals Corp |
TOPICAL FORMULATIONS FOR THE TREATMENT OF PSORIASIS
|
|
EP2259790A1
(en)
|
2008-02-07 |
2010-12-15 |
Gilead Palo Alto, Inc. |
Abca-1 elevating compounds and the use thereof
|
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
|
US8993580B2
(en)
|
2008-03-14 |
2015-03-31 |
Intellikine Llc |
Benzothiazole kinase inhibitors and methods of use
|
|
WO2009117157A1
(en)
|
2008-03-20 |
2009-09-24 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
|
JP2011520970A
(ja)
*
|
2008-05-19 |
2011-07-21 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
置換されたイミダゾピラジン類およびイミダゾトリアジン類
|
|
US20090312406A1
(en)
|
2008-06-12 |
2009-12-17 |
Hsing-Pang Hsieh |
Coumarin compounds and their use for treating viral infection
|
|
MX2011000216A
(es)
|
2008-07-08 |
2011-03-29 |
Intellikine Inc |
Inhibidores de cinasa y metodos para su uso.
|
|
US20110224223A1
(en)
|
2008-07-08 |
2011-09-15 |
The Regents Of The University Of California, A California Corporation |
MTOR Modulators and Uses Thereof
|
|
EP2328897A1
(en)
|
2008-07-16 |
2011-06-08 |
Schering Corporation |
Bicyclic heterocycle derivatives and their use as gpcr modulators
|
|
US8450344B2
(en)
|
2008-07-25 |
2013-05-28 |
Aerie Pharmaceuticals, Inc. |
Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
|
|
EP2331525A4
(en)
|
2008-08-11 |
2013-01-02 |
Harvard College |
HALOFUGINONE ANALOGUE FOR INHIBITING TRNA SYNTHETASES AND APPLICATIONS THEREOF
|
|
AU2009298877A1
(en)
|
2008-09-23 |
2010-04-08 |
Georgetown University |
Viral and fungal inhibitors
|
|
WO2010036380A1
(en)
|
2008-09-26 |
2010-04-01 |
Intellikine, Inc. |
Heterocyclic kinase inhibitors
|
|
WO2010045542A2
(en)
|
2008-10-16 |
2010-04-22 |
The Regents Of The University Of California |
Fused ring heteroaryl kinase inhibitors
|
|
US8476431B2
(en)
|
2008-11-03 |
2013-07-02 |
Itellikine LLC |
Benzoxazole kinase inhibitors and methods of use
|
|
US20110269779A1
(en)
|
2008-11-18 |
2011-11-03 |
Intellikine, Inc. |
Methods and compositions for treatment of ophthalmic conditions
|
|
WO2010129816A2
(en)
|
2009-05-07 |
2010-11-11 |
Intellikine, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN101602768B
(zh)
|
2009-07-17 |
2012-05-30 |
河南省农科院农副产品加工研究所 |
一种芝麻素和芝麻林素的提纯方法
|
|
EP2485731B1
(en)
|
2009-10-06 |
2016-05-11 |
Millennium Pharmaceuticals, Inc. |
Heterocyclic compounds useful as pdk1 inhibitors
|
|
WO2011047384A2
(en)
|
2009-10-16 |
2011-04-21 |
The Regents Of The University Of California |
Methods of inhibiting ire1
|
|
EP2528919B1
(en)
*
|
2010-01-28 |
2016-11-02 |
University of Washington |
Compositions and methods for treating toxoplasmosis. cryptosporidiosis and other apicomplexan protozoan related diseases
|
|
US9040714B2
(en)
|
2010-04-05 |
2015-05-26 |
Mannkind Corporation |
IRE-1α inhibitors
|
|
JP5951600B2
(ja)
|
2010-05-21 |
2016-07-13 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
キナーゼ調節のための、化合物、組成物および方法
|
|
WO2012064774A1
(en)
|
2010-11-10 |
2012-05-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
An ire1alpha endonuclease specific inhibitor with cytotoxic activity
|
|
JP6130305B2
(ja)
|
2011-02-23 |
2017-05-17 |
インテリカイン， エルエルシー |
キナーゼ阻害剤の組み合わせおよびそれらの使用
|
|
EP2548877A1
(en)
*
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
CN106243113B
(zh)
*
|
2011-07-19 |
2018-12-18 |
默沙东有限责任公司 |
作为btk抑制剂的选择的咪唑并吡嗪类
|
|
MX370814B
(es)
|
2011-09-02 |
2020-01-08 |
Univ California |
Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
|
|
WO2014052669A1
(en)
|
2012-09-26 |
2014-04-03 |
The Regents Of The University Of California |
Modulation of ire1
|
|
WO2016004254A1
(en)
|
2014-07-01 |
2016-01-07 |
The Regents Of The University Of California |
Combined modulation of ire1
|